Решетов Игорь Владимирович


Сортировать:

2206 ClinicalTrials.gov

Статус: Completed
Фаза: Phase 1
Начало: 24 апреля 2020 г.
Окончание: 30 июля 2020 г.
Описание: According to the epidemiological situation worldwide and the number of vaccinations made, there is little success in the fight against COVID-19. For many reasons, methylene blue is a promising drug for an active treatment against SARS-CoV-2 infected patients. Since methylene blue can work as a photosensitizer, photodynamic therapy as an antiviral treatment has great potential in the treatment of COVID-19. This clinical study investigated the effectiveness of SARS-CoV-2 infected people treatment using methylene blue and the following photodynamic therapy on the base of the L.L. Levshin Institute of Cluster Oncology (Department of Infectious Diseases №13) of I.M. Sechenov First Moscow State Medical University.
смотреть на ClinicalTrials.gov